SHANE OLWILL

Person

Freising-Weihenstephan, DE

People

Patents Grantslast 30 patents

Information Patent Grant
Proteins specific for CD137
- Patent number 12,195,503
- Issue date Jan 14, 2025
- Pieris Pharmaceuticals GmbH
- Marlon Hinner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-cancer fusion polypeptide capable of binding both CD137 and gl...
- Patent number 11,919,931
- Issue date Mar 5, 2024
- Pieris Pharmaceuticals GmbH
- Marlon Hinner
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Lipocalin muteins with binding affinity for LAG-3
- Patent number 11,773,147
- Issue date Oct 3, 2023
- Pieris Pharmaceuticals GmbH
- Christine Rothe
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Proteins specific for CD137
- Patent number 11,261,221
- Issue date Mar 1, 2022
- Pieris Pharmaceuticals GmbH
- Marlon Hinner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Lipocalin muteins with binding affinity for LAG-3
- Patent number 11,168,119
- Issue date Nov 9, 2021
- Pieris Pharmaceuticals GmbH
- Christine Rothe
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Nucleic acid molecules encoding human neutrophil gelatinase-associa...
- Patent number 11,034,738
- Issue date Jun 15, 2021
- Pieris Pharmaceuticals GmbH
- Rachida SIham Bel Aiba
- G01 - MEASURING TESTING
Information Patent Grant
Human tear lipocalin muteins which specifically bind lymphocyte act...
- Patent number 10,927,156
- Issue date Feb 23, 2021
- Pieris Pharmaceuticals GmbH
- Christine Rothe
- G01 - MEASURING TESTING
Information Patent Grant
Multi-specific polypeptide useful for localized tumor immunomodulation
- Patent number 10,927,154
- Issue date Feb 23, 2021
- Pieris Pharmaceuticals GmbH
- Shane Olwill
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-cancer fusion polypeptides, encoding nucleic acids and methods...
- Patent number 10,913,778
- Issue date Feb 9, 2021
- Pieris Pharmaceuticals GmbH
- Marlon Hinner
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-cancer fusion polypeptide
- Patent number 10,865,250
- Issue date Dec 15, 2020
- Pieris Pharmaceuticals GmbH
- Marlon Hinner
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fusion polypeptides which bind vascular endothelial growth factor a...
- Patent number 10,703,810
- Issue date Jul 7, 2020
- Pieris Australia Pty Ltd.
- Shane Olwill
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Human neutrophil gelatinase-associated lipocalin (hNGAL) muteins ca...
- Patent number 10,526,382
- Issue date Jan 7, 2020
- Pieris Pharmaceuticals GmbH
- Rachida SIham Bel Aiba
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Interleukin-17A-specific and interleukin-23-specific binding polype...
- Patent number 10,526,384
- Issue date Jan 7, 2020
- Pieris Pharmaceuticals GmbH
- Marlon Hinner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Muteins of human tear lipocalin capable of binding lymphocyte-activ...
- Patent number 10,501,510
- Issue date Dec 10, 2019
- Pieris Pharmaceuticals GmbH
- Christine Rothe
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and compositions for treating disorders
- Patent number 10,064,963
- Issue date Sep 4, 2018
- Pieris Pharmaceuticals GmbH
- Shane Olwill
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
HER2/4-1BB BISPECIFIC FUSION PROTEINS FOR THE TREATMENT OF CANCER
- Publication number 20240166764
- Publication date May 23, 2024
- Pieris Pharmaceuticals GmbH
- Markus ZETTL
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HER2/4-1BB BISPECIFIC FUSION PROTEINS FOR THE TREATMENT OF CANCER
- Publication number 20240166763
- Publication date May 23, 2024
- Pieris Pharmaceuticals GmbH
- Shane OLWILL
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MULTIMERIC IMMUNOMODULATOR TARGETING 4-1BB
- Publication number 20230227568
- Publication date Jul 20, 2023
- Pieris Pharmaceuticals GmbH
- Janet PEPER-GABRIEL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Novel Fusion Proteins Specific for CD137 and GPC3
- Publication number 20220153864
- Publication date May 19, 2022
- Pieris Pharmaceuticals GmbH
- Rachida Siham BEL AIBA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL PROTEINS SPECIFIC FOR CD137
- Publication number 20220144901
- Publication date May 12, 2022
- Pieris Pharmaceuticals GmbH
- Marlon HINNER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
LIPOCALIN MUTEINS WITH BINDING AFFINITY FOR LAG-3
- Publication number 20220098253
- Publication date Mar 31, 2022
- Pieris Pharmaceuticals GmbH
- Christine Rothe
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-CANCER FUSION POLYPEPTIDE
- Publication number 20210403516
- Publication date Dec 30, 2021
- Pieris Pharmaceuticals GmbH
- Marlon Hinner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL FUSION PROTEIN SPECIFIC FOR CD137 AND PD-L1
- Publication number 20210363257
- Publication date Nov 25, 2021
- Pieris Pharmaceuticals GmbH
- Marina Pavlidou
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPIES COMPRISING CD137/HER2 BISPECIFIC AGENTS AND P...
- Publication number 20210246219
- Publication date Aug 12, 2021
- Pieris Pharmaceuticals GmbH
- Ingmar Bruns
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-CANCER FUSION POLYPEPTIDE
- Publication number 20210198380
- Publication date Jul 1, 2021
- Pieris Pharmaceuticals GmbH
- Marlon Hinner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL INTERLEUKIN-17A-SPECIFIC AND INTERLEUKIN-23-SPECIFIC BINDING...
- Publication number 20200148733
- Publication date May 14, 2020
- Pieris Pharmaceuticals GmbH
- Marlon Hinner
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL PROTEINS SPECIFIC FOR ANGIOGENESIS
- Publication number 20200140501
- Publication date May 7, 2020
- Pieris Pharmaceuticals GmbH
- Rachida Siham BEL AIBA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL PROTEINS SPECIFIC FOR LAG-3
- Publication number 20200048317
- Publication date Feb 13, 2020
- Pieris Pharmaceuticals GmbH
- Christine ROTHE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
LIPOCALIN MUTEINS WITH BINDING AFFINITY FOR LAG-3
- Publication number 20190345207
- Publication date Nov 14, 2019
- Pieris Pharmaceuticals GmbH
- Christine Rothe
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL PROTEINS SPECIFIC FOR LAG-3
- Publication number 20190031729
- Publication date Jan 31, 2019
- Pieris Pharmaceuticals GmbH
- Christine ROTHE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CANCER FUSION POLYPEPTIDE
- Publication number 20190010248
- Publication date Jan 10, 2019
- Pieris Pharmaceuticals GmbH
- Marlon HINNER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL FUSION POLYPEPTIDE SPECIFIC FOR LAG-3 AND PD-1
- Publication number 20190010231
- Publication date Jan 10, 2019
- Pieris Pharmaceuticals GmbH
- Christine ROTHE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL ANTI-ANGIOGENIC FUSION POLYPEPTIDES
- Publication number 20180334499
- Publication date Nov 22, 2018
- Pieris Australia Pty Ltd.
- Shane Olwill
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL PROTEINS SPECIFIC FOR CD137
- Publication number 20180148484
- Publication date May 31, 2018
- Pieris Pharmaceuticals GmbH
- Marlon HINNER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CANCER FUSION POLYPEPTIDE
- Publication number 20180148485
- Publication date May 31, 2018
- Pieris Pharmaceuticals GmbH
- Marlon HINNER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL PROTEINS SPECIFIC FOR ANGIOGENESIS
- Publication number 20180016312
- Publication date Jan 18, 2018
- Pieris Pharmaceuticals GmbH
- Rachida Siham BEL AIBA
- G01 - MEASURING TESTING
Information Patent Application
LIPOCALIN MUTEINS WITH BINDING-AFFINITY FOR GLYPICAN-3 (GPC-3) AND...
- Publication number 20170066807
- Publication date Mar 9, 2017
- Pieris Pharmaceuticals GmbH
- SHANE OLWILL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MULTI-SPECIFIC POLYPEPTIDE USEFUL FOR LOCALIZED TUMOR IMMUNOMODULATION
- Publication number 20160362460
- Publication date Dec 15, 2016
- Pieris Pharmaceuticals GmbH
- SHANE OLWILL
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL SPECIFIC-BINDING PROTEINS AND USES THEREOF
- Publication number 20150344538
- Publication date Dec 3, 2015
- PIERIS AG
- Marlon HINNER
- G01 - MEASURING TESTING
Information Patent Application
METHODS FOR PREVENTING, TREATING OR DIAGNOSING DISORDERS
- Publication number 20150004098
- Publication date Jan 1, 2015
- PIERIS AG
- Shane Olwill
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

SHANE OLWILL

Person

Patents Grantslast 30 patents

Proteins specific for CD137

Anti-cancer fusion polypeptide capable of binding both CD137 and gl...

Lipocalin muteins with binding affinity for LAG-3

Proteins specific for CD137

Lipocalin muteins with binding affinity for LAG-3

Nucleic acid molecules encoding human neutrophil gelatinase-associa...

Human tear lipocalin muteins which specifically bind lymphocyte act...

Multi-specific polypeptide useful for localized tumor immunomodulation

Anti-cancer fusion polypeptides, encoding nucleic acids and methods...

Anti-cancer fusion polypeptide

Fusion polypeptides which bind vascular endothelial growth factor a...

Human neutrophil gelatinase-associated lipocalin (hNGAL) muteins ca...

Interleukin-17A-specific and interleukin-23-specific binding polype...

Muteins of human tear lipocalin capable of binding lymphocyte-activ...

Methods and compositions for treating disorders

Patents Applicationslast 30 patents

HER2/4-1BB BISPECIFIC FUSION PROTEINS FOR THE TREATMENT OF CANCER

HER2/4-1BB BISPECIFIC FUSION PROTEINS FOR THE TREATMENT OF CANCER

MULTIMERIC IMMUNOMODULATOR TARGETING 4-1BB

Novel Fusion Proteins Specific for CD137 and GPC3

NOVEL PROTEINS SPECIFIC FOR CD137

LIPOCALIN MUTEINS WITH BINDING AFFINITY FOR LAG-3

ANTI-CANCER FUSION POLYPEPTIDE

NOVEL FUSION PROTEIN SPECIFIC FOR CD137 AND PD-L1

COMBINATION THERAPIES COMPRISING CD137/HER2 BISPECIFIC AGENTS AND P...

ANTI-CANCER FUSION POLYPEPTIDE

NOVEL INTERLEUKIN-17A-SPECIFIC AND INTERLEUKIN-23-SPECIFIC BINDING...

NOVEL PROTEINS SPECIFIC FOR ANGIOGENESIS

NOVEL PROTEINS SPECIFIC FOR LAG-3

LIPOCALIN MUTEINS WITH BINDING AFFINITY FOR LAG-3

NOVEL PROTEINS SPECIFIC FOR LAG-3

ANTI-CANCER FUSION POLYPEPTIDE

NOVEL FUSION POLYPEPTIDE SPECIFIC FOR LAG-3 AND PD-1

NOVEL ANTI-ANGIOGENIC FUSION POLYPEPTIDES

NOVEL PROTEINS SPECIFIC FOR CD137

ANTI-CANCER FUSION POLYPEPTIDE

NOVEL PROTEINS SPECIFIC FOR ANGIOGENESIS

LIPOCALIN MUTEINS WITH BINDING-AFFINITY FOR GLYPICAN-3 (GPC-3) AND...

MULTI-SPECIFIC POLYPEPTIDE USEFUL FOR LOCALIZED TUMOR IMMUNOMODULATION

NOVEL SPECIFIC-BINDING PROTEINS AND USES THEREOF

METHODS FOR PREVENTING, TREATING OR DIAGNOSING DISORDERS